Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DSKYF
Recent news which mentions DSKYF
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients
September 23, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
DSNKY
Benzinga
Market News
From
Benzinga
AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
September 10, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
DSKYF
Top Stories
Stories That Matter
From
Benzinga
Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This Analyst's Top 10
August 07, 2024
Tickers
ALCPF
ASIA
DSKYF
DSNKY
Tags
Asia
News
NVDA
From
Benzinga
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
July 30, 2024
Tickers
DSKYF
DSNKY
MRK
NEWS
Tags
General
why it's moving
News
From
Benzinga
FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
June 27, 2024
Tickers
DSKYF
DSNKY
MRK
NEWS
Tags
DSKYF
Top Stories
Stories That Matter
From
Benzinga
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Tickers
ARWR
DSKYF
MRK
NEWS
Tags
XBI
Stories That Matter
ARWR
From
Benzinga
Why Is AstraZeneca Stock Trading Lower On Tuesday?
May 28, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
Top Stories
DSKYF
Stories That Matter
From
Benzinga
Double Good News For AstraZeneca's Breast Cancer Drugs
April 29, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
Briefs
News
General
From
Benzinga
AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor
April 08, 2024
Tickers
AZN
DSKYF
DSNKY
NEWS
Tags
AZN
Biotech
Briefs
From
Benzinga
What's Going On With Pfizer Stock Today?
January 25, 2024
Tickers
DSKYF
DSNKY
NEWS
PFE
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development
October 20, 2023
Tickers
AZN
DSKYF
MRK
Tags
News
Briefs
General
From
Benzinga
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
Health Care
Large Cap
Biotech
From
Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
Tickers
AZN
DSKYF
DSNKY
Tags
AZN
Large Cap
Biotech
From
Benzinga
FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
July 21, 2023
Tickers
DSKYF
DSNKY
NVS
Tags
General
News
Briefs
From
Benzinga
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
July 03, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Biotech
AZN
Equities
From
Benzinga
Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact
March 20, 2023
Tickers
DSKYF
DSNKY
ZYME
Tags
DSKYF
Briefs
News
From
Benzinga
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting
March 06, 2023
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Health Care
AZN
Large Cap
From
Benzinga
Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine
January 13, 2023
Tickers
DSKYF
DSNKY
Tags
DSNKY
Benzinga
Market News
From
Benzinga
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSKYF
Briefs
News
From
Benzinga
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Benzinga
DSNKY
Market News
From
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Biotech
AZN
Health Care
From
Benzinga
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
August 15, 2022
Tickers
DSKYF
DSNKY
MRK
SGEN
Tags
General
Legal
News
From
Benzinga
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
August 15, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
Briefs
General
From
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
August 12, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSKYF
General
News
From
Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Benzinga
DSNKY
Market News
From
Benzinga
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
July 19, 2022
Tickers
ACAD
APLS
AVDL
AZN
Tags
FDA
Trading Ideas
BVNKF
From
Benzinga
AstraZeneca's Enhertu Wins European Approval For Pretreated Breast Cancer Setting
July 19, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
News
Briefs
General
From
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
ALPMF
AZN
Contracts
From
Benzinga
EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies
June 27, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Large Cap
Biotech
AZN
From
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 6
June 06, 2022
Tickers
AAPL
AMD
AXON
AZN
Tags
GOOGL
JJNC
TWTR
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.